ARCHIVES

NCI Prepares For Intramural Program Review

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995